Abstract:Objectives: To develop a deep learning (DL) model for differentiating between osteolytic osteosarcoma (OS) and giant cell tumor (GCT) on radiographs. Methods: Patients with osteolytic OS and GCT proven by postoperative pathology were retrospectively recruited from four centers (center A, training and internal testing; centers B, C, and D, external testing). Sixteen radiologists with different experiences in musculoskeletal imaging diagnosis were divided into three groups and participated with or without the DL model's assistance. DL model was generated using EfficientNet-B6 architecture, and the clinical model was trained using clinical variables. The performance of various models was compared using McNemar's test. Results: Three hundred thirty-three patients were included (mean age, 27 years ± 12 [SD]; 186 men). Compared to the clinical model, the DL model achieved a higher area under the curve (AUC) in both the internal (0.97 vs. 0.77, p = 0.008) and external test set (0.97 vs. 0.64, p < 0.001). In the total test set (including the internal and external test sets), the DL model achieved higher accuracy than the junior expert committee (93.1% vs. 72.4%; p < 0.001) and was comparable to the intermediate and senior expert committee (93.1% vs. 88.8%, p = 0.25; 87.1%, p = 0.35). With DL model assistance, the accuracy of the junior expert committee was improved from 72.4% to 91.4% (p = 0.051). Conclusion: The DL model accurately distinguished osteolytic OS and GCT with better performance than the junior radiologists, whose own diagnostic performances were significantly improved with the aid of the model, indicating the potential for the differential diagnosis of the two bone tumors on radiographs. Critical relevance statement: The deep learning model can accurately distinguish osteolytic osteosarcoma and giant cell tumor on radiographs, which may help radiologists improve the diagnostic accuracy of two types of tumors. Key points: • The DL model shows robust performance in distinguishing osteolytic osteosarcoma and giant cell tumor. • The diagnosis performance of the DL model is better than junior radiologists'. • The DL model shows potential for differentiating osteolytic osteosarcoma and giant cell tumor.

High‐quality expert annotations enhance artificial intelligence model accuracy for osteosarcoma X‐ray diagnosis

AI based diagnostics product design for osteosarcoma cells microscopy imaging of bone cancer patients using CA-MobileNet V3

Exploiting Biochemical Data to Improve Osteosarcoma Diagnosis with Deep Learning

Deep learning-based detection of primary bone tumors around the knee joint on radiographs: a multicenter study

Deep learning for differentiation of osteolytic osteosarcoma and giant cell tumor around the knee joint on radiographs: a multicenter study

Magnetic Resonance Imaging Texture Analysis Based on Intraosseous and Extraosseous Lesions to Predict Prognosis in Patients with Osteosarcoma

Advanced Hybrid Deep Learning Model for Enhanced Classification of Osteosarcoma Histopathology Images

Interpretable clinical visualization model for prediction of prognosis in osteosarcoma: a large cohort data study

Clinical Application of Artificial Intelligence: Auto-Discerning the Effectiveness of Lidocaine Concentration Levels in Osteosarcoma Femoral Tumor Segment Resection

Artificial Intelligence (AI) Assisted CT/MRI Image Fusion Technique in Preoperative Evaluation of a Pelvic Bone Osteosarcoma

Diagnostic Performance of Artificial Intelligence in Detection of Primary Malignant Bone Tumors: a Meta-Analysis

Artificial intelligence in skeletal metastasis imaging

Survival Prediction in High-grade Osteosarcoma Using Radiomics of Diagnostic Computed Tomography

A deep learning study on osteosarcoma detection from histological images

Anemia Risk Prediction Model for Osteosarcoma Patients Post‐Chemotherapy Using Artificial Intelligence

The Potential for Different Computed Tomography-Based Machine Learning Networks to Automatically Segment and Differentiate Pelvic and Sacral Osteosarcoma from Ewing's Sarcoma

Clinical-radiomics models based on plain X-rays for prediction of lung metastasis in patients with osteosarcoma

The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma

Intelligent Segmentation Medical Assistance System for MRI Images of Osteosarcoma in Developing Countries

Prediction of Neoadjuvant Chemotherapy Response in High-Grade Osteosarcoma: Added Value of Non-Tumorous Bone Radiomics Using CT Images.

Development of a deep learning method for improving diagnostic accuracy for uterine sarcoma cases